drugset / Trial / NCT06600607
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
RandomizedCrossoverTriple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled within-participant crossover study in healthy male participants 18-55 years of age to assess pain tolerance during a cold pressor test. The study will be conducted at a single center in New Zealand.
Timeline
- Start
- 2024-10-07
- Primary completion
- 2024-10-27
- Completion
- 2024-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 300 mg | — |
Indications
No indication recorded.